D-Dimer-based Indication for Transesophageal Echocardiography to Exclude Left Atrial Thrombus Before Cardioversion of Non-anticoagulated Atrial Fibrillation: A Multicenter Belgian Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1368 participants.

Also called NCT04784039

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 1,368 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04784039
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04784039. Randomized; no masking; primary purpose prevention. Start 2025-01-01 (anticipated); primary completion 2026-01-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
D-Dimer-based Indication for Transesophageal Echocardiography to Exclude Left Atrial Thrombus Before Cardioversion of Non-anticoagulated Atrial Fibrillation: A Multicenter Belgian Study
Acronym
CARDDI-BEL
Intervention (Diagnostic test)
Transesophageal echocardiography
Intervention (Diagnostic test)
D-Dimer analysis
Lead sponsor
AZ Sint-Jan AV (class: other)

Record details

Record id
cardio:ct-nct04784039
Content hash
080fba8b5184c8144d0000e23a2d856bc77917ca9d46c0de6f7b740f94f36b79